{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:13:19Z","timestamp":1790511199591,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Methods"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.crmeth.2022.100297","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T10:34:41Z","timestamp":1663583681000},"page":"100297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Deep-learning analysis of micropattern-based organoids enables high-throughput drug screening of Huntington\u2019s disease models"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6813-4425","authenticated-orcid":false,"given":"Jakob J.","family":"Metzger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1625-215X","authenticated-orcid":false,"given":"Carlota","family":"Pereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Haremaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Galgoczi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Siggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H.","family":"Brivanlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Etoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crmeth.2022.100297_bib1","doi-asserted-by":"crossref","first-page":"1600244","DOI":"10.1002\/bies.201600244","article-title":"Dawn of the organoid era","volume":"39","author":"Akkerman","year":"2017","journal-title":"Bioessays"},{"key":"10.1016\/j.crmeth.2022.100297_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.aax3338","article-title":"Huntington\u2019s disease alters human neurodevelopment","volume":"369","author":"Barnat","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2022.100297_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-319-53889-1_15","article-title":"Epigenetics of Huntington\u2019s disease","volume":"978","author":"Bassi","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.crmeth.2022.100297_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","volume":"37","author":"Becht","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.crmeth.2022.100297_bib5","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41592-019-0582-9","article-title":"ilastik: interactive machine learning for (bio)image analysis","volume":"16","author":"Berg","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.crmeth.2022.100297_bib6","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/nprot.2016.105","article-title":"Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes","volume":"11","author":"Bray","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.crmeth.2022.100297_bib7","doi-asserted-by":"crossref","first-page":"dev179093","DOI":"10.1242\/dev.179093","article-title":"A novel self-organizing embryonic stem cell system reveals signaling logic underlying the patterning of human ectoderm","volume":"146","author":"Britton","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.crmeth.2022.100297_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molmed.2017.02.007","article-title":"Disease modeling in stem cell-derived 3D organoid systems","volume":"23","author":"Dutta","year":"2017","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.crmeth.2022.100297_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.devcel.2016.09.016","article-title":"A balance between secreted inhibitors and edge sensing controls gastruloid self-organization","volume":"39","author":"Etoc","year":"2016","journal-title":"Dev. Cell"},{"key":"10.1016\/j.crmeth.2022.100297_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JHD-140134","article-title":"Epigenetic mechanisms involved in Huntington\u2019s disease pathogenesis","volume":"4","author":"Glajch","year":"2015","journal-title":"J.\u00a0Huntingtons Dis."},{"key":"10.1016\/j.crmeth.2022.100297_bib11","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/s41587-019-0237-5","article-title":"Self-organizing neuruloids model developmental aspects of Huntington\u2019s disease in the ectodermal compartment","volume":"37","author":"Haremaki","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.crmeth.2022.100297_bib12","first-page":"770","article-title":"Deep residual learning for image recognition","volume":"2016","author":"He","year":"2016","journal-title":"IEEE Conference on Computer Vision and Pattern Recognition (CVPR)"},{"key":"10.1016\/j.crmeth.2022.100297_bib13","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3390\/info11020108","article-title":"Fastai: a layered API for deep learning","volume":"11","author":"Howard","year":"2020","journal-title":"Information"},{"key":"10.1016\/j.crmeth.2022.100297_bib14","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1073\/pnas.1415195112","article-title":"HDAC inhibition imparts beneficial transgenerational effects in Huntington\u2019s disease mice via altered DNA and histone methylation","volume":"112","author":"Jia","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.crmeth.2022.100297_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddz264","article-title":"Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6\/2 Huntington\u2019s disease mice","volume":"29","author":"Kedaigle","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.crmeth.2022.100297_bib16","series-title":"Proc. 3rd Int. Conf. Learn. Represent. ICLR 2015","article-title":"Adam: a method for stochastic optimization","author":"Kingma","year":"2015"},{"key":"10.1016\/j.crmeth.2022.100297_bib17","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.crmeth.2022.100297_bib18","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.039347","article-title":"Disease modelling in human organoids","volume":"12","author":"Lancaster","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.crmeth.2022.100297_bib19","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jamaneurol.2020.0299","article-title":"Huntingtin-Lowering therapies for Huntington disease: a review of the evidence of potential benefits and risks","volume":"77","author":"Leavitt","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.crmeth.2022.100297_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-019-1722-1","article-title":"Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds","volume":"575","author":"Li","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.crmeth.2022.100297_bib21","doi-asserted-by":"crossref","first-page":"e96854","DOI":"10.1371\/journal.pone.0096854","article-title":"Quantification assays for total and polyglutamine-expanded Huntingtin proteins","volume":"9","author":"Macdonald","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.crmeth.2022.100297_bib22","first-page":"49","article-title":"On the generalized distance in statistics","volume":"2","author":"Mahalanobis","year":"1936","journal-title":"Proc. Natl. Inst. Sci. India"},{"key":"10.1016\/j.crmeth.2022.100297_bib23","doi-asserted-by":"crossref","first-page":"E2146","DOI":"10.3390\/ijms21062146","article-title":"Huntingtin lowering strategies","volume":"21","author":"Marxreiter","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.crmeth.2022.100297_bib24","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1093\/hmg\/ddv080","article-title":"HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicity","volume":"24","author":"Mattis","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.crmeth.2022.100297_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrd.2017.111","article-title":"Opportunities and challenges in phenotypic drug discovery: an industry perspective","volume":"16","author":"Moffat","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.crmeth.2022.100297_bib26","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1017\/S1462399411001992","article-title":"Bromodomains as therapeutic targets","volume":"13","author":"Muller","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.crmeth.2022.100297_bib27","series-title":"The Building Blocks of Interpretability","author":"Olah","year":"2018"},{"key":"10.1016\/j.crmeth.2022.100297_bib28","series-title":"Advances in Neural Information Processing Systems","article-title":"PyTorch: an imperative style, high-performance deep learning library","author":"Paszke","year":"2019"},{"key":"10.1016\/j.crmeth.2022.100297_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.addr.2014.02.006","article-title":"Drug discovery through stem cell-based organoid models","volume":"69\u201370","author":"Ranga","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.crmeth.2022.100297_bib30","doi-asserted-by":"crossref","first-page":"e52904","DOI":"10.7554\/eLife.52904","article-title":"A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids","volume":"9","author":"Renner","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.crmeth.2022.100297_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.crmeth.2022.100297_bib32","doi-asserted-by":"crossref","first-page":"dev156844","DOI":"10.1242\/dev.156844","article-title":"Chromosomal instability during neurogenesis in Huntington\u2019s disease","volume":"145","author":"Ruzo","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.crmeth.2022.100297_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40263-019-00695-3","article-title":"Recent advances in the treatment of Huntington\u2019s disease: targeting DNA and RNA","volume":"34","author":"Shannon","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.crmeth.2022.100297_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.phrs.2015.08.002","article-title":"Transcriptional dysregulation in Huntington\u2019s disease: the role of histone deacetylases","volume":"100","author":"Sharma","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.crmeth.2022.100297_bib35","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/nprot.2012.116","article-title":"Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks","volume":"7","author":"Shi","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.crmeth.2022.100297_bib36","doi-asserted-by":"crossref","first-page":"E8765","DOI":"10.1073\/pnas.1807962115","article-title":"Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition","volume":"115","author":"Siebzehnr\u00fcbl","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.crmeth.2022.100297_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/toxsci\/kfy218","article-title":"Functional and mechanistic neurotoxicity profiling using human iPSC-derived neural 3D cultures","volume":"167","author":"Sirenko","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.crmeth.2022.100297_bib38","article-title":"A disciplined approach to neural network hyper-parameters: Part 1--learning rate, batch size, momentum, and weight decay","author":"Smith","year":"2018","journal-title":"ArXiv"},{"key":"10.1016\/j.crmeth.2022.100297_bib39","doi-asserted-by":"crossref","first-page":"D431","DOI":"10.1093\/nar\/gkz1023","article-title":"LINCS Data Portal 2.0: next generation access point for perturbation-response signatures","volume":"48","author":"Stathias","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.crmeth.2022.100297_bib40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/clpt.2012.236","article-title":"Phenotypic vs. Target-based drug discovery for first-in-class medicines","volume":"93","author":"Swinney","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.crmeth.2022.100297_bib41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","article-title":"How were new medicines discovered?","volume":"10","author":"Swinney","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.crmeth.2022.100297_bib42","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting Huntingtin expression in patients with Huntington\u2019s disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.crmeth.2022.100297_bib43","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington\u2019s disease transgenic mice","volume":"105","author":"Thomas","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.crmeth.2022.100297_bib44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","article-title":"Estimation of clinical trial success rates and related parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"key":"10.1016\/j.crmeth.2022.100297_bib45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical\u00a0parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.crmeth.2022.100297_bib46","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.drudis.2013.07.001","article-title":"Phenotypic screens as a renewed approach for drug discovery","volume":"18","author":"Zheng","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.crmeth.2022.100297_bib47","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease","volume":"90","author":"Zuccato","year":"2010","journal-title":"Physiol. Rev."}],"container-title":["Cell Reports Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237522001795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667237522001795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:01:18Z","timestamp":1757404878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667237522001795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2667237522001795"],"URL":"https:\/\/doi.org\/10.1016\/j.crmeth.2022.100297","relation":{},"ISSN":["2667-2375"],"issn-type":[{"value":"2667-2375","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep-learning analysis of micropattern-based organoids enables high-throughput drug screening of Huntington\u2019s disease models","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmeth.2022.100297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"100297"}}